Keith Devas
Stock Analyst at Jefferies
(0.53)
# 4,123
Out of 4,534 analysts
27
Total ratings
14.3%
Success rate
-11.6%
Average return
Main Sectors:
Stocks Rated by Keith Devas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Reiterated: Buy | $785 → $792 | $563.81 | +40.47% | 4 | May 6, 2026 | |
| PBH Prestige Consumer Healthcare | Maintained: Hold | $71 → $66 | $50.41 | +30.93% | 4 | Jan 30, 2026 | |
| KVUE Kenvue | Downgraded: Hold | $23 → $18 | $19.02 | -5.36% | 15 | Jan 30, 2026 | |
| PRGO Perrigo Company | Maintained: Hold | $27 → $23 | $10.59 | +117.19% | 4 | Oct 27, 2025 |
IDEXX Laboratories
May 6, 2026
Reiterated: Buy
Price Target: $785 → $792
Current: $563.81
Upside: +40.47%
Prestige Consumer Healthcare
Jan 30, 2026
Maintained: Hold
Price Target: $71 → $66
Current: $50.41
Upside: +30.93%
Kenvue
Jan 30, 2026
Downgraded: Hold
Price Target: $23 → $18
Current: $19.02
Upside: -5.36%
Perrigo Company
Oct 27, 2025
Maintained: Hold
Price Target: $27 → $23
Current: $10.59
Upside: +117.19%